Transdermal technologies

Company news

19 Jun 2019

News4
Collaboration with OBJ to commercialise transdermal cannabis technologies

Little Green Pharma is pleased to announce a collaboration agreement with OBJ. Little Green Pharma and OBJ will contribute equally to the Curtin Research and Development services in Western Australia with the adaptation of the transdermal technology to deliver cannabinoid therapy transdermally, with a view to the joint ownership and commercialisation of the technology.

If the cannabinoid trials at Curtin University are successful in demonstrating that cannabinoids can effectively use OBJ’s micro-array technology:

  • this could result in one of the most advanced and effective medicinal cannabis delivery systems developed in the world, to date; and
  • the OBJ joint venture with Little Green Pharma could rapidly develop both its own products as well as licensing the technology to third parties for rapid distribution worldwide. Little Green Pharma operates from one of the few fully-licensed GMP certified medicinal cannabis manufacturing facilities in Australia.

Little Green Pharma is currently the only Australian medicinal cannabis company producing locally-grown and -manufactured GMP cannabis products for patients. Little Green Pharma cultivates locally grown medicinal cannabis from a secure facility in Western Australia and distributes its products nationally.

For the full media release and to read more about this exciting new partnership please visit: http://www.obj.com.au/wp-content/uploads/2019/06/02115462.pdf

You might also be interested in

Quest News

Insights

The QUEST initiative is launched!
Little Green Pharma is proud to announce that it is sponsoring an Australia-wide medical cannabis study called the QUEST Initiative

Mar 2021

Pharmacy

Insights

TGA announces final CBD down-scheduling
Registered CBD products to be dispensed over-the-counter without a prescription

Dec 2020

STATS 310321 FB 940x788

Insights

Industry update: March 2021
The TGA approval numbers just keep on climbing

Apr 2021

View all articles